It's Just an Endpoint, Right?
Mari Welke | MA, Director, Safety & Innovation, Certara Synchrogenix
Endpoints are critical to successful clinical trial design, but they can also be challenging. This discussion will focus on the many facets of study endpoints, including how simple variations in wording can change the meaning, often without intent. Also discussed will be possible downstream impacts of protocol endpoints in other documents and deliverables. Strategies for writing protocol endpoints will be discussed.